Clinical Trial Update: Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age.

View source ↗

Summary

An ongoing clinical trial is evaluating whether Nirsevimab reduces hospitalizations due to RSV infection in infants under one year; the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Nirsevimab (nirsevimab)

Snippet

Sponsor: Meyer Children's Hospital IRCCS | Conditions: Respiratory Synctial Virus Infections | Status: RECRUITING